One of the stocks to have emerged as a notable gainer this past Friday was that of Regen Biopharma (OTCMKTS:RGBP). The stock came on to the radars of investors after the publication of the transcript of the discussion and analyses in relation to the
On Friday, investors piled on to the stock in a big way as the Regen stock ended the day with gains company’s financial situation as well as operations results. of as much as 19%. In this situation, it might be a good idea to take a look at some of the important points from the management discussion.
It emerged that as of September 30, 2020, the company had account receivables to the tune of $103,192 and at the end of December 31, 2020, Regen had account receivables of as much as $130607.
The rise in the amount for account receivables came about due to the receipt of anniversary fees and royalties due to the fact that it had been granted by the company to Zander. The publication of this transcript provided important details about the company’s business and interested investors could do well to take a look at it. Investors could keep an eye on the Regen stock this week.